Liping Fu Selected Research

Tyrosine Kinase Inhibitors

1/2023

Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liping Fu Research Topics

Disease

8	Neoplasms (Cancer) 01/2024 - 07/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2015
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023 - 11/2021
3	Cognitive Dysfunction 01/2022 - 08/2015
2	Stomach Neoplasms (Stomach Cancer) 03/2024 - 02/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2023
2	Amyloidosis 01/2022 - 11/2012
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 07/2011
2	HIV Infections (HIV Infection) 04/2015 - 03/2012
1	Adenocarcinoma 03/2024
1	Adenocarcinoma of Lung 01/2024
1	Inflammation (Inflammations) 12/2023
1	Osteoarthritis 12/2023
1	Sclerosis 12/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Calcinosis 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022
1	Multiple Myeloma 04/2022
1	Primary Progressive Aphasia 01/2022
1	Pain (Aches) 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Sepsis (Septicemia) 01/2022
1	Wounds and Injuries (Trauma) 03/2021
1	Amyloid Plaque 01/2021
1	Cough 11/2020
1	Polyps 08/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2018
1	Pica (Geophagia) 01/2018
1	Lymphatic Metastasis 01/2017
1	Atrophy 08/2015
1	Substance-Related Disorders (Drug Abuse) 04/2015
1	Opioid-Related Disorders (Opiate Addiction) 09/2014
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 11/2012
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2012
1	Familial primary gastric lymphoma 01/2012

Drug/Important Bio-Agent (IBA)

4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2015
3	Naloxone Drug Combination Buprenorphine FDA Link 04/2015 - 03/2012
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 01/2018
2	Opioid Analgesics (Opioids)IBA 04/2015 - 03/2012
1	Sincalide FDA Link 01/2024
1	dihydroquinoxalinoneIBA 01/2023
1	dezocine FDA Link 01/2023
1	acceleratory factor from growth hormone (AcG)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Midazolam (Versed)FDA LinkGeneric 01/2023
1	Proteasome InhibitorsIBA 04/2022
1	PeptidomimeticsIBA 04/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2022
1	Bortezomib (Velcade)FDA Link 04/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	eupalinolide OIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	6- ((3- fluoro- 2- hydroxy)propoxy)- 2- (4- methylaminophenyl)quinolineIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Hazardous Substances (Hazardous Materials)IBA 03/2021
1	Long Noncoding RNAIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	LuciferasesIBA 01/2021
1	C-Reactive ProteinIBA 11/2020
1	mesoglycanIBA 08/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2012
1	Drug CombinationsIBA 03/2012
1	Sodium SeleniteIBA 07/2011
1	Selenious Acid (Selenite)IBA 07/2011
1	SeleniumIBA 07/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2024 - 12/2023
2	Radiotherapy 01/2024 - 11/2021
2	Analgesia 01/2023 - 01/2022
1	Neoadjuvant Therapy 03/2024
1	Therapeutics 12/2023
1	Moxibustion 12/2023
1	Segmental Mastectomy (Lumpectomy) 11/2021
1	Immunotherapy 02/2021